Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.
Press releases published on August 25, 2025
MagVenture Receives FDA Clearance to Expand TMS Therapy Indication for Adolescents Aged 15–21
EIN Presswire
·
August 25, 2025
ALPHARETTA, GA, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- MagVenture, the global leader of non-invasive TMS neuromodulation technology, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for an expanded …
Tango Zen: Revealing the Hidden Tango Tradition in Buenos Aires and Beyond
EIN Presswire
·
August 25, 2025
Experience the world premiere of a film that reveals tango’s forgotten essence—an embrace of presence, energy, and tradition. BUENOS AIRES, ARGENTINA, August 25, 2025 /EINPresswire.com/ -- Tango Zen World Premiere Discover the soul of tango that was …
CYPFER Enters New Chapter with Legendary Streetball Icon 'The Professor'
EIN Presswire
·
August 25, 2025
The Professor and CYPFER unite to elevate the conversation around digital resilience, personal empowerment, and global impact. MIAMI, FL, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- MIAMI / NEW YORK / TORONTO / LONDON / DUBAI / MEXICO / …
Snow Sports Accessories Market to Total US$ 1,799 Million by 2035, Expanding at a 2.5% CAGR- Fact.MR Studys
EIN Presswire
·
August 25, 2025
Snow Sports Accessories Market driven by winter tourism, safety gear demand, and innovation in high-performance equipment for skiing …
XS.com Gana el Premio a la “Mejor Investigación de Mercado” en Money Expo India 2025
EIN Presswire
·
August 25, 2025
COLOMBIA, August 25, 2025 /Business News/ -- XS.com, la principal firma global de FinTech y corretaje multi-activos, fue galardonada con el premio a la “Mejor Investigación de Mercado” en Money Expo India 2025, celebrado los días 23 y 24 de agosto en el …
XS.com Ganha o Prêmio de “Melhor Pesquisa de Mercado” no Money Expo India 2025
EIN Presswire
·
August 25, 2025
BRAZIL, August 25, 2025 /Business News/ -- A XS.com, a principal empresa global de FinTech e corretora multiativos, foi premiada com o título de “Melhor Pesquisa de Mercado” no Money Expo India 2025, realizado nos dias 23 e 24 de agosto no Jio World …
Las Vegas Author Releases ‘The Chicken and the Eagle’ to Inspire Kids to Embrace Their God-Given Identity
EIN Presswire
·
August 25, 2025
Las Vegas author Johnny Morales debuts ‘The Chicken and the Eagle,’ inspiring children to embrace their identity and soar with confidence. LAS VEGAS, NV, UNITED STATES, August 24, 2025 /EINPresswire.com/ -- Las Vegas author Johnny Morales announces the …
Caribe LNG Signs a Strategic Financing Partnership with ArtCap to Advance Colombia’s First FSU-Based LNG Import Terminal
EIN Presswire
·
August 25, 2025
Partnership strengthens the project’s capital structure and ensures resources for critical infrastructure. MIAMI, FL, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- Caribe LNG announced today a strategic financing partnership with ArtCap …
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
GlobeNewswire
·
August 25, 2025
DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
GlobeNewswire
·
August 25, 2025
JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …
Avalyn to Participate in Multiple Upcoming Investor Conferences in September
GlobeNewswire
·
August 25, 2025
CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management …
Ardelyx to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Fate Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
GlobeNewswire
·
August 25, 2025
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …
BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025
GlobeNewswire
·
August 25, 2025
PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire oral presentation on …
Spectral Medical Receives US$3 Million From Vantive
GlobeNewswire
·
August 25, 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has received the US$3 million …
Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
GlobeNewswire
·
August 25, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …
Major Drilling to Release Results for its First Quarter on September 8, 2025
GlobeNewswire
·
August 25, 2025
MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended July 31, 2025, on Monday, September 8, 2025 after the markets have closed. Webcast/ …
Apollo Expands Project Team; Receives Drill Permit for Calico Silver Project
GlobeNewswire
·
August 25, 2025
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a number of positive developments at its Calico Silver Project (“Calico” or the …
Erdene Provides Update on Share Consolidation
GlobeNewswire
·
August 25, 2025
HALIFAX, Nova Scotia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX: ERD; MSE: ERDN; OTCQB: ERDCF) ("Erdene" or the "Company") is pleased to provide an update on the proposed consolidation (the "Consolidation") of Company's …